Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies

Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies

With widespread global COVID-19 vaccine coverage, a scalable, cost-effective, and standardized tool to ascertain post-vaccine immunity is a dire need. Neither clinical evaluations of vaccine efficacy, nor live virus antibody neutralization assays fulfill these criteria. Commercially available anti-S...

Full description

Bibliographic Details
Main Authors: Javeria Aijaz, Fatima Kanani, Fouzia Naseer
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Journal of Clinical Virology Plus
Subjects:
Roche
Elecsys
COVID-19
Antibodies
Neutralizing
Online Access:http://www.sciencedirect.com/science/article/pii/S2667038023000042

Internet

http://www.sciencedirect.com/science/article/pii/S2667038023000042

Similar Items